Related Experiment Video
Updated: Aug 11, 2026

11:06
Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
Detection of chemical mutagens using Muta Mouse: a transgenic mouse model
A J Hoorn1, L L Custer, B C Myhr
1Hazleton Washington, Inc, Vienna, VA 22182.
Mutagenesis
|January 1, 1993
Summary
This study shows a transgenic mouse model effectively detects gene mutations in organs like bone marrow, liver, and testes. It
Area of Science:
- Genetics and Molecular Biology
- Toxicology and Mutagenesis Research
Background:
- Assessing the genotoxic potential of chemical compounds requires sensitive and specific detection methods.
- Transgenic models offer a powerful platform for studying gene mutations in vivo.
Purpose of the Study:
- To evaluate a transgenic mouse model for its efficacy in detecting lacZ- mutations across various tissues.
- To determine the utility of this model for studying organ-specific mutagenicity and germ cell susceptibility.
Main Methods:
- A transgenic mouse strain with high-copy rescuable lacZ sequences was utilized.
- Mice were exposed to various mutagens including procarbazine, cyclophosphamide, ethylnitrosourea, DMBA, acrylamide, and chlorambucil.
- Mutant frequencies were analyzed in target tissues: bone marrow, liver, skin, and testis.
Main Results:
- Significant increases in mutant frequencies were observed in bone marrow, liver, and testis following exposure to ethylnitrosourea and chlorambucil.
- Mutation induction was confirmed in bone marrow after exposure to procarbazine, cyclophosphamide, and acrylamide.
- Dermal application of DMBA induced mutations in skin tissue.
Conclusions:
- The transgenic mouse model is highly effective for detecting and analyzing gene mutations in multiple organs, including germinal tissues.
- This model is suitable for investigating organ-specific chemical mutagens, carcinogens, and the susceptibility of germ cells to mutagenic agents.
Related Concept Videos
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

